155 254

Cited 21 times in

Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer

DC FieldValueLanguage
dc.contributor.author송시영-
dc.contributor.author윤미진-
dc.contributor.author이우정-
dc.contributor.author이재훈-
dc.contributor.author이종두-
dc.contributor.author조응혁-
dc.contributor.author최혜진-
dc.contributor.author강창무-
dc.contributor.author김주항-
dc.date.accessioned2014-12-18T09:40:31Z-
dc.date.available2014-12-18T09:40:31Z-
dc.date.issued2013-
dc.identifier.issn0513-5796-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/88615-
dc.description.abstractPURPOSE: We evaluated the prognostic value of (18)F-2-fluoro-2-deoxyglucose positron emission tomography (FDG PET) in patients with resectable pancreatic cancer. MATERIALS AND METHODS: We retrospectively reviewed the medical records of pancreatic cancer patients who underwent curative resection, which included 64 consecutive patients who had preoperative FDG PET scans. For statistical analysis, the maximal standardized uptake value (SUVmax) of primary pancreatic cancer was measured. Survival time was estimated by the Kaplan-Meier method, and Cox's proportional hazard model was used to determine whether SUVmax added new predictive information concerning survival together with known prognostic factors. p<0.05 indicated statistical significance. RESULTS: Overall survival (OS) and disease- free survival (DFS) were respectively 42.9 months (27.6-58.2; 95% CI) and 14.9 months (10.1-19.7; 95% CI). When subjects were divided into two groups according to SUVmax with a cutoff value of 3.5, the high SUVmax group (n=32; SUVmax >3.5) showed significantly shorter OS and DFS than the low SUVmax group. Multivariate analysis of OS and DFS showed that both high SUVmax and poor tumor differentiation were independent poor prognostic factors. CONCLUSION: Our study showed that degree of FDG uptake was an independent prognostic factor in pancreatic cancer patients who underwent curative resection.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.relation.isPartOfYONSEI MEDICAL JOURNAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHFluorodeoxyglucose F18*-
dc.subject.MESHHumans-
dc.subject.MESHLymphatic Metastasis-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPancreatic Neoplasms/diagnostic imaging*-
dc.subject.MESHPancreatic Neoplasms/pathology*-
dc.subject.MESHPancreatic Neoplasms/surgery-
dc.subject.MESHPositron Emission Tomography Computed Tomography*-
dc.titlePrognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Nuclear Medicine (핵의학)-
dc.contributor.googleauthorHye Jin Choi-
dc.contributor.googleauthorChang Moo Kang-
dc.contributor.googleauthorWoo Jung Lee-
dc.contributor.googleauthorSi Young Song-
dc.contributor.googleauthorArthur Cho-
dc.contributor.googleauthorMijin Yun-
dc.contributor.googleauthorJong Doo Lee-
dc.contributor.googleauthorJoo Hang Kim-
dc.contributor.googleauthorJae-Hoon Lee-
dc.identifier.doi10.3349/ymj.2013.54.6.1377-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02035-
dc.contributor.localIdA02550-
dc.contributor.localIdA03138-
dc.contributor.localIdA03887-
dc.contributor.localIdA04219-
dc.contributor.localIdA00088-
dc.contributor.localIdA00945-
dc.contributor.localIdA02993-
dc.contributor.localIdA03093-
dc.relation.journalcodeJ02813-
dc.identifier.eissn1976-2437-
dc.identifier.pmid29893751-
dc.subject.keyworddisease-free survival-
dc.subject.keywordfluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography-
dc.subject.keywordlymph node metastasis-
dc.subject.keywordlymph node to tumor standardized uptake value ratio-
dc.subject.keywordoverall survival-
dc.subject.keywordpancreatic cancer-
dc.contributor.alternativeNameSong, Si Young-
dc.contributor.alternativeNameYun, Mi Jin-
dc.contributor.alternativeNameLee, Woo Jung-
dc.contributor.alternativeNameLee, Jae Hoon-
dc.contributor.alternativeNameLee, Jong Doo-
dc.contributor.alternativeNameCho, Arthur Eung Hyuck-
dc.contributor.alternativeNameChoi, Hye Jin-
dc.contributor.alternativeNameKang, Chang Moo-
dc.contributor.alternativeNameKim, Joo Hang-
dc.contributor.affiliatedAuthorSong, Si Young-
dc.contributor.affiliatedAuthorYun, Mi Jin-
dc.contributor.affiliatedAuthorLee, Jong Doo-
dc.contributor.affiliatedAuthorCho, Arthur Eung Hyuck-
dc.contributor.affiliatedAuthorChoi, Hye Jin-
dc.contributor.affiliatedAuthorKang, Chang Moo-
dc.contributor.affiliatedAuthorKim, Joo Hang-
dc.contributor.affiliatedAuthorLee, Woo Jung-
dc.contributor.affiliatedAuthorLee, Jae Hoon-
dc.rights.accessRightsfree-
dc.citation.volume54-
dc.citation.number6-
dc.citation.startPage1377-
dc.citation.endPage1383-
dc.identifier.bibliographicCitationYONSEI MEDICAL JOURNAL, Vol.54(6) : 1377-1383, 2013-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.